-
Dovitinib (TKI-258) for Mechanism-Driven Assays
2026-08-27
Dovitinib enables a practical perturbation workflow for connecting broad RTK signaling with proliferation, apoptosis, and metastatic phenotypes in cancer models. This article translates the circRHOBTB3–NONO–MAOA findings in prostate cancer into assay choices while clearly separating established product biology from exploratory applications.
-
Oxaliplatin and the Logic of Tumor Heterogeneity
2026-08-27
Oxaliplatin is more than a cytotoxic benchmark: it is a translational probe for studying DNA damage, apoptosis, metastatic evolution, and therapeutic heterogeneity in colorectal cancer models.
-
LMO2–LDB1 Complex Drives AML Cell Maintenance
2026-08-26
The 2023 Cell Death and Disease study identifies LDB1 as a functional partner and dependency of LMO2 in acute myeloid leukemia (AML). By combining perturbation assays, protein-interaction analysis, transcriptomics, ChIP-seq, and rescue experiments, the authors connect the LMO2/LDB1 complex with AML cell proliferation, survival, and apoptosis-related gene regulation.
-
How Nuclear ERK Shapes Translation in Cardiomyocytes
2026-08-26
Uchida and colleagues identify a compartment-specific mechanism in which nuclear ERK phosphorylates 4EBP1 at Ser64 to reposition translation toward the cardiomyocyte interior during concentric hypertrophy. The study distinguishes mTORC1 control of overall translation from ERK-dependent spatial organization, offering a framework for interpreting how kinase localization can shape cell architecture.
-
PTGER4–HDAC Signaling in Rectal Epithelium
2026-08-25
Anbazhagan et al. identify a stromal–epithelial signaling mechanism in which mesenchymal stromal cell-derived PGE2 activates PTGER4 and alters class IIa HDAC phosphorylation in rectal organoids. The pathway increases SPINK4 mRNA and extracellular SPINK4, providing a mechanistic framework for epithelial repair and for interpreting PTGER4 activity in inflammatory bowel disease.
-
From Epitope Maps to Human IgG Readouts
2026-08-25
How M1R/B6R antibody discovery informs translational assay design, and where a Cy3-conjugated anti-human IgG secondary antibody can strengthen the evidence chain without overstating antiviral validation.
-
Nifedipine: Calcium Assay Design Beyond PXR Models
2026-08-24
Nifedipine (BAY-a-1040) is more than an L-type calcium channel blocker: it is a useful perturbation tool for separating calcium-dependent phenotypes from transcriptional and metabolic adaptation. This article connects rigorous calcium, viability, iron-transport, and pathogen assays with lessons from a recent PXR rat study.
-
Open-Platform DLP for 96-Well Hydrogel Printing
2026-08-24
Mathis and colleagues introduce a low-cost, open-platform digital light printer that fabricates patterned 2D hydrogels and locally activates photocaged DNA in 96-well formats. Its LabVIEW control, planar correction, wavelength flexibility, and vessel compatibility address reproducibility and customization constraints in high-throughput biomaterials workflows.
-
Acetylcysteine for Redox Assay Design
2026-08-23
Learn how Acetylcysteine and N-acetyl-L-cysteine can be deployed as controllable redox perturbation tools in cell, organoid, hepatic, respiratory, and neurodegeneration workflows. The article also translates a photothermal–immune nanoplatform study into practical assay controls without implying that NAC was part of the original formulation.
-
Phosbind Acrylamide for Phosphorylation Analysis
2026-08-22
Phosbind Acrylamide enables antibody-independent visualization of phosphorylation-dependent mobility shifts directly in SDS-PAGE. This article translates the reagent into practical workflows for stress signaling, kinase assays, and plant defense research while emphasizing controls, optimization, and assay limitations.
-
Dovitinib (TKI-258) Experimental Workflows
2026-08-22
Dovitinib (TKI-258, CHIR-258) supports mechanism-focused studies of FLT3, c-Kit, FGFR, VEGFR, and PDGFR signaling in cancer models. This guide translates its multitarget profile into practical workflows for pathway validation, apoptosis induction, library design, and troubleshooting.
-
Chemistry of Silybin: Structure, Separation, and Derivatives
2026-08-21
Křen and colleagues provide a comprehensive chemistry-focused analysis of silybin, linking its stereochemical assignment to isolation, diastereomer separation, total synthesis, and derivative development. The review clarifies why distinguishing individual flavonolignans from the broader Silymarin mixture is essential for reproducible analytical, mechanistic, and translational research.
-
β-Elemene: Mechanisms and Cell-Model Evidence
2026-08-20
β-Elemene, also called Levo-β-elemene, is a C15H24 sesquiterpene used in apoptosis, metabolic, inflammation, and neuroprotection research. In a 3T3-L1 adipocyte model, β-elemene reduced lipid accumulation and improved insulin-resistance-associated changes through AMPK pathway activation.
-
Measuring Drug Responses in Cancer In Vitro
2026-08-20
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating growth inhibition from cell killing and interpreting their distinct proportions and timing, improving the design of in vitro studies and the evaluation of cancer epigenetics experiments.
-
LY2603618: Chk1 Inhibitor Workflow Guide
2026-08-19
LY2603618 enables controlled interrogation of Chk1-dependent replication-stress survival, G2/M checkpoint signaling, and chemotherapy sensitization. This workflow connects DNA-damage readouts with the thioredoxin–ribonucleotide reductase axis to improve responder profiling in non-small cell lung cancer research.